Home
News
Create
Screeners
Insights
Fabtech Technologies
155.
77
-3.03
(-1.91%)
Market Cap
₹692.41 Cr
PE Ratio
22.59
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.91%
1M
-12.10%
6M
-14.60%
1Y
-14.60%
5Y
-14.60%
View Company Insights
Latest news about Fabtech Technologies
Fabtech Technologies Secures USD 7.05 Million International Contract from West Africa
6 days ago
Fabtech Technologies Limited secured a USD 7.05 million international contract from a West Africa company on February 14, 2026, for supply, installation and commissioning of Oral Solid Dosage facility infrastructure. The project will be executed within 23-27 months from advance receipt, with the client's name withheld due to confidentiality. The contract, worth approximately Rs. 63.6 crores, does not involve related party transactions.
Fabtech Technologies Q3FY26 Earnings Call Reveals Revenue Timing Issues, Strong Order Book
10 days ago
Fabtech Technologies Makes Q3FY26 Earnings Call Recording Available Online
Feb 05, 2026
Fabtech Technologies Reports Q3FY26 Results with ₹567.79L Loss and Risk Committee Dissolution
Feb 02, 2026
Fabtech Technologies Cleanrooms Secures ₹330 Million Order
Dec 19, 2025
More news about Fabtech Technologies
18
Nov 25
Fabtech Technologies Clarifies Corporate Identity: Separate from Fabtech Technologies Cleanrooms Ltd
Fabtech Technologies Limited (FTL) has issued a statement to address market confusion, emphasizing its separate identity from Fabtech Technologies Cleanrooms Limited (FTCL). FTL and FTCL are independent, listed companies with distinct management teams and business strategies. FTL focuses on international turnkey life sciences infrastructure across 62 countries, while FTCL primarily serves India's cleanroom infrastructure needs. The companies have different stock listings, symbols, and ISINs. This clarification aims to prevent investor confusion and ensure accurate market representation.
14
Nov 25
Fabtech Technologies Reports 109.9% Revenue Growth in H1 FY26, Expands Global Footprint
Fabtech Technologies Limited, a global turnkey engineering solutions provider for pharmaceutical sectors, reported robust H1 FY2026 results. Total income reached INR 19,322.80 lakhs, up 109.9% year-on-year. Net profit increased by 101.6% to INR 2,198.02 lakhs. EBITDA improved to INR 2,839.99 lakhs with margins at 14.7%. The company maintains a strong order book of INR 90,441.87 lakhs as of July 31, 2025, with 7-9% growth from July to September 2025. Operating in 22 countries, Fabtech focuses on MENA, GCC, and ECO Zone regions, offering end-to-end turnkey solutions for pharmaceutical manufacturing. The company's asset-light model and in-house manufacturing capabilities enhance execution agility and cost efficiency.
06
Nov 25
Fabtech Technologies Reports Robust Q2 FY26 Results with 109.91% Revenue Growth, Targets Expansion in Bio-Pharma Sector
Fabtech Technologies Limited announced impressive Q2 FY26 results, with total income rising 109.91% YoY to ₹12,427.61 crores. Net profit surged 449.12% to ₹2,810.61 crores, while EBITDA margin expanded to 27.06%. The company's current order book stands at ₹90,441.87 lakhs, with operations across 62 countries. Fabtech is targeting growth in bio-pharma equipment, modular facilities, and engineering turnkey projects, leveraging its expertise in pharmaceutical and healthcare engineering solutions.
04
Nov 25
Fabtech Technologies Reports Net Loss in Q1 FY26, Strong Rebound in Q2
Fabtech Technologies Limited reported a significant turnaround in Q2 FY26, with revenue increasing 78.6% to ₹12,148.07 lakhs and net profit reaching ₹2,810.61 lakhs, compared to a loss in Q1. The company completed its IPO and listed on NSE and BSE in October 2025. Additionally, Fabtech secured a ₹52 crore contract for a veterinary formulations facility in North Africa, boosting its order book to ₹983.05 crore. An earnings call is scheduled for November 10, 2025, to discuss Q1 and Q2 FY26 results.
03
Nov 25
Fabtech Technologies Secures ₹52 Crore Contract for Veterinary Facility in North Africa
Fabtech Technologies Limited (FTL) has won a ₹52 crore contract to build a veterinary medicines manufacturing facility in North Africa's Maghreb region. The project includes complete design, engineering, cleanroom systems, utilities, and process equipment. This addition boosts FTL's cumulative order book to ₹983.05 crore. The Maghreb veterinary formulation market is projected to reach USD 500-700 million by 2030, driven by increasing demand for animal health products and food security goals. This contract marks FTL's strategic expansion in both human and animal healthcare sectors, leveraging its in-house capabilities to capitalize on growing markets.
Fabtech Technologies
155.
77
-
3.
03
(-
1.
91
%)
1 Year Returns:
-14.60%
Industry Peers
Poly Medicure
1,255.80
(-
1.
76
%)
Laxmi Dental
194.29
(-
1.
42
%)
Tarsons Products
195.50
(-
0.
56
%)
Osel Devices
475.35
(-
2.
45
%)
Vasa Denticity
481.65
(-
3.
67
%)
Fabtech Technologies
155.77
(-
1.
91
%)
Prevest Denpro
480.00
(+
2.
79
%)
Aprameya Engineering
227.85
(-
0.
39
%)
Hemant Surgical Industries
292.55
(-
1.
48
%)
Nureca
291.80
(+
2.
28
%)
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation